Belimumab Treatment of Emphysema Patients With Anti-GRP78 Autoantibodies
Clinical trial NCT03244059 · COMPLETED
Trial details
- NCT number
- NCT03244059
- Sponsor
- University of Alabama at Birmingham
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-09
- Primary completion
- 2022-04-01
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.